Karlan BY - Search Results

1

FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.

Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Karlan BY, Berek JS, Farias-Eisner R. Memarzadeh S, et al. Among authors: karlan by. Int J Gynecol Cancer. 2002 Sep-Oct;12(5):454-8. doi: 10.1046/j.1525-1438.2002.01149.x. Int J Gynecol Cancer. 2002. PMID: 12366662

2

The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery.

Farias-Eisner R, Teng F, Oliveira M, Leuchter R, Karlan B, Lagasse LD, Berek JS. Farias-Eisner R, et al. Gynecol Oncol. 1994 Oct;55(1):108-10. doi: 10.1006/gyno.1994.1257. Gynecol Oncol. 1994. PMID: 7959250

3

Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease.

Farias-Eisner R, Cirisano FD, Grouse D, Leuchter RS, Karlan BY, Lagasse LD, Berek JS. Farias-Eisner R, et al. Among authors: karlan by. Gynecol Oncol. 1994 Apr;53(1):55-8. doi: 10.1006/gyno.1994.1087. Gynecol Oncol. 1994. PMID: 8175023 Clinical Trial.

4

The etiology and management of diarrhea in the gynecologic oncology patient.

Cirisano FD, Greenspoon JS, Stenson R, Farias-Eisner R, Karlan BY, Lagasse LD. Cirisano FD, et al. Among authors: karlan by. Gynecol Oncol. 1993 Jul;50(1):45-8. doi: 10.1006/gyno.1993.1162. Gynecol Oncol. 1993. PMID: 8349164

5

Perioperative coagulopathy in patients undergoing primary cytoreduction.

Brown JV, Karlan BY, Greenspoon JS, Rosove MH, Lagasse LD. Brown JV, et al. Among authors: karlan by. Cancer. 1993 Apr 15;71(8):2557-61. doi: 10.1002/1097-0142(19930415)71:8<2557::aid-cncr2820710820>3.0.co;2-3. Cancer. 1993. PMID: 8453579

6

What is the role of reassessment laparoscopy in the management of gynecologic cancers in 1995?

Casey AC, Farias-Eisner R, Pisani AL, Cirisano FD, Kim YB, Muderspach L, Futoran R, Leuchter RS, Lagasse LD, Karlan BY. Casey AC, et al. Among authors: karlan by. Gynecol Oncol. 1996 Mar;60(3):454-61. doi: 10.1006/gyno.1996.0073. Gynecol Oncol. 1996. PMID: 8774657

7

The risk of ovarian cancer after treatment for infertility.

Bristow RE, Karlan BY. Bristow RE, et al. Among authors: karlan by. Curr Opin Obstet Gynecol. 1996 Feb;8(1):32-7. Curr Opin Obstet Gynecol. 1996. PMID: 8777256 Review.

8

Ovulation induction, infertility, and ovarian cancer risk.

Bristow RE, Karlan BY. Bristow RE, et al. Among authors: karlan by. Fertil Steril. 1996 Oct;66(4):499-507. doi: 10.1016/s0015-0282(16)58557-4. Fertil Steril. 1996. PMID: 8816606 Free article. Review.

9

Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature.

Bristow RE, Lagasse LD, Karlan BY. Bristow RE, et al. Among authors: karlan by. Cancer. 1996 Nov 15;78(10):2049-62. Cancer. 1996. PMID: 8918397

10

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.

Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Bristow RE, et al. Among authors: karlan by. Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. Gynecol Oncol. 1999. PMID: 10053096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters